1-1 of 1
John H. Musser, Ph.D.
Close
Sort by
Journal Articles

Preclinical Development of Triptolide Derivative MRx102 as a Therapeutic Agent for Acute Myeloid Leukemia

John M. Fidler, Ph.D., Jinhua An, Ph.D., John H. Musser, Ph.D., Duncan H. Mak, M.S., Bing Carter, Ph.D., Michael Andreeff, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3271.
https://doi.org/10.1182/blood.V116.21.3271.3271
Published: 2010